Polyrizon completes clinical site network for NASARIX study
Polyrizon says it has completed the clinical site network for its NASARIX study and is advancing toward patient enrollment, with no catalyst or timing details supplied.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.